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Abstract
Background: This study’s purpose investigated the impact of different macronutrient distributions and varying
caloric intakes along with regular exercise for metabolic and physiological changes related to weight loss.
Methods: One hundred forty-one sedentary, obese women (38.7 ± 8.0 yrs, 163.3 ± 6.9 cm, 93.2 ± 16.5 kg, 35.0 ±
6.2 kg•m-2, 44.8 ± 4.2% fat) were randomized to either no diet + no exercise control group (CON) a no diet +
exercise control (ND), or one of four diet + exercise groups (high-energy diet [HED], very low carbohydrate, high
protein diet [VLCHP], low carbohydrate, moderate protein diet [LCMP] and high carbohydrate, low protein [HCLP])
in addition to beginning a 3x•week-1 supervised resistance training program. After 0, 1, 10 and 14 weeks, all
participants completed testing sessions which included anthropometric, body composition, energy expenditure,
fasting blood samples, aerobic and muscular fitness assessments. Data were analyzed using repeated measures
ANOVA with an alpha of 0.05 with LSD post-hoc analysis when appropriate.
Results: All dieting groups exhibited adequate compliance to their prescribed diet regimen as energy and
macronutrient amounts and distributions were close to prescribed amounts. Those groups that followed a diet and
exercise program reported significantly greater anthropometric (waist circumference and body mass) and body
composition via DXA (fat mass and % fat) changes. Caloric restriction initially reduced energy expenditure, but
successfully returned to baseline values after 10 weeks of dieting and exercising. Significant fitness improvements
(aerobic capacity and maximal strength) occurred in all exercising groups. No significant changes occurred in lipid
panel constituents, but serum insulin and HOMA-IR values decreased in the VLCHP group. Significant reductions in
serum leptin occurred in all caloric restriction + exercise groups after 14 weeks, which were unchanged in other
non-diet/non-exercise groups.
Conclusions: Overall and over the entire test period, all diet groups which restricted their caloric intake and
exercised experienced similar responses to each other. Regular exercise and modest caloric restriction successfully
promoted anthropometric and body composition improvements along with various markers of muscular fitness.
Significant increases in relative energy expenditure and reductions in circulating leptin were found in response to
all exercise and diet groups. Macronutrient distribution may impact circulating levels of insulin and overall ability to
improve strength levels in obese women who follow regular exercise.
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Introduction
The prevalence of obesity in the U.S and throughout the
world continues to increase. Comprehensive reviews on
the topic estimate that 1.2 billion people in the world
are overweight and at least 300 million of them are
obese [1]. While largely thought to be preventable, obe-
sity is linked to an estimated 300,000 deaths in the U.S.
every year. Not just concerns related to excessive weight,
obesity is also strongly linked to other disorders such as
hypertension, diabetes, hypercholesterolemia, and liver
disease. As a result, much research is being conducted
worldwide to help identify causative mechanisms as well
as programs to better manage its progression. Recently,
many investigations have focused on increasing the pro-
portion of dietary protein relative to carbohydrate to
examine changes in weight loss, body composition and
energy expenditure as well as various serum markers of
substrate utilization and appetite regulation [2-5]. Many
of these studies have reported these types of diets to
have positive effects on weight loss as well as markers of
disease risk, which include body composition, blood
lipids and glucose and insulin kinetics [2,6,7], while
other studies in obese populations have reported no dif-
ference in weight loss [8], but favorable effects on other
markers of disease risk [5,9,10].
A higher protein intake in overweight and obese
populations has been indicated for many reasons,
including a better regulation of glucose and insulin
homeostasis and prevention of lean muscle loss; an
effect closely related with programs of substantial reduc-
tions in dietary energy intake [6,7]. Studies which incor-
porated insulin resistant, metabolic syndrome or those
diagnosed as with type II diabetes reported that diets
with a higher protein intake stimulate greater weight
loss and improvements in glucose homeostasis and cho-
lesterol status [2,5] as well as overall improvements in
the incidence of metabolic syndrome [4,11]. Addition-
ally, much interest in various adipokines (e.g. resistin,
leptin, adiponectin) has been generated due to their
relationship to appetite, energy expenditure, insulin sen-
sitivity and cardiovascular disease [12,13]. While many
studies have reported upon the relationship between
acute changes in circulating levels of leptin in healthy
[13], overweight [3,14,15] and diabetic populations [16],
the impact of these responses relative to higher
protein and higher carbohydrate requires additional
investigation.
In addition to dietary modifications, the inclusion of
more physical activity is often indicated to stimulate
weight loss [17-21], increase energy expenditure [19]
and promote improvements in insulin sensitivity [20,21]
as well as other indicators of cardiovascular disease risk
[17,19-21]. While much research has been conducted
highlighting the benefits of even modest amounts of
physical activity, a small number of studies have
reported upon the impact of an exercise program with
various dietary interventions of which can include calo-
ric restriction and alterations in the ratio of dietary
protein and dietary carbohydrate [3,4,22,23]. Further-
more, even less scientific literature has reported upon
physiological as well as biochemical adaptations that
occur following this type of dieting in combination with
resistance-based exercise [3,22]. While cardiovascular
forms of exercise are more popular, findings from these
studies suggest that combining dietary interventions
with a resistance-based exercise program promotes
changes in weight loss and improvements in risks for
cardiovascular disease, but also attenuate losses in lean
mass which commonly occurs in dietary programs
which severely restrict energy intake [19,22] as well as
promote a greater maintenance of energy expenditure
[3,19] and insulin sensitivity [24]. The present study is
the second of a series of investigations conducted by
our research group to examine the changes in body
composition, fitness and health while participating in a
weekly, resistive exercise program. Two major advances
were studied in the present investigation. A shorter
hypocaloric period (one week vs. two weeks) was uti-
lized as a means to stimulate weight loss but minimize
the negative metabolic influence seen in the first investi-
gation [3]. Second, a modified weight maintenance
approach was adopted over the last four weeks of the
present study. The ideal outcome from these modifica-
tions were to develop a diet and exercise program that
promoted a healthy amount of weight loss that could be
sustained without negative and otherwise untoward
effects of the program itself (e.g. maintenance of fat-free
mass and energy expenditure) [25].
For these reasons, the purpose of this study was to
elucidate the impact of different macronutrient distribu-
tions in conjunction with a regular exercise program
and to further examine dietary strategies which comple-
ment the workout regimen employed by this investiga-
tion. The specific aims of this study were to determine
the impact of combining various dietary interventions
with a resistance exercise program on changes in weight
loss, body composition, cardiovascular and muscular fit-
ness parameters, resting energy expenditure, and serum
markers of clinical safety and substrate utilization in
sedentary, obese women. It was hypothesized that all
exercise and diet groups would significantly lose weight
and experience significant improvements in their fitness.
Further, we hypothesized that consumption of a diet
with a higher proportion of dietary protein would
further stimulate positive adaptations in body composi-
tion and markers of cardiovascular disease risk [22].
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Methods
Experimental Approach
This study was designed as a follow-up to an initial
study by our group [3] which was designed to assess the
overall safety and efficacy of following the exercise and
diet recommendations of the Curves program. The pre-
sent follow-up study sought to determine the impact of
an initial one week bout of intensive caloric restriction
of varying macronutrient ratios followed by a moderate
caloric restriction diet of varying macronutrient ratios
while participating in a regular exercise program. In
concert with our previous research design, participants
were matched into clusters according to age and body
mass and placed into one of six diet and exercise combi-
nations [3].
The first phase of dieting (Phase I) lasted one week.
During this time, participants were assigned to follow the
prescribed exercise program and follow one of four diet
+ exercise combinations (presented as kcals; % carbohy-
drate: protein: fat): 1) a high energy, high carbohydrate,
low protein diet (HED) [2,600; 55:15:30%], 2) a very low
carbohydrate, high protein diet (VLCHP) [1,200;
7:63:30%], 3) a low carbohydrate, moderate protein diet
(LCMP) [1,200; 20:50:30%], or 4) a high carbohydrate,
low protein diet (HCLP) [1,200; 55:15:30%]. Phase II
lasted for last for nine weeks, increased caloric intake in
all restricted groups to 1,600 calories per day and chan-
ged the macronutrient ratios of VLCHP and HCLP to
1,600; 15:55:30%. Further, the HED group altered their
macronutrient ratio to 2,600; 40:30:30%. Phase III was a
four week period which had all participants follow the
same diet (2,600; 55:15:30%) and participants were
instructed to weigh themselves each day. Upon gaining
three pounds, participants were told to follow their phase
I diet until the additional weight was lost. All subjects
were tested over the course of a 14 week period at 0, 1,
10, and 14 weeks to determine any changes in criterion
variables. We hypothesized throughout this study that
participating in the diet and exercise programs would
facilitate weight loss in addition to improvements in var-
ious indicators of health in comparison to the control
groups (CON and ND+E). Two additional aims were pre-
sent which included a continued investigation into the
impact caused by alterations in the macronutrient ratio
(higher protein vs. higher carbohydrate) for their efficacy
at facilitating weight loss and promoting health. In this
regard, we have hypothesized that those dietary groups
which contained higher amounts of dietary protein
would experience smaller reductions in lean tissue mass
in comparison to other diet groups. The remaining aim
was centered on acute alterations in caloric intake and its
impact on energy expenditure, selected metabolic hor-
mones and subsequent weight loss and health changes.
Towards this aim we hypothesized that acute alterations
would facilitate weight maintenance while allowing for
periods of higher and lower caloric intake. According to
these hypotheses, primary outcomes in this study were
identified as waist circumference; secondary outcomes
were body mass and DXA parameters while tertiary out-
comes were the changes seen in cardio respiratory and
muscular fitness, resting energy expenditure, serum and
whole blood safety and hormonal markers. A standard
consort diagram is available which outlines the numbers
of participants who were screened (n = 260), assigned to
a group (n = 216), including how many to each interven-
tion group and those that completed the entire 14 week
protocol (n = 141) (see Figure 1).
Subjects
One-hundred forty-one sedentary, obese women (38.7 ±
8.0 yrs, 163 ± 7 cm, 93.2 ± 16.5 kg, 35.0 ± 6.2 kg•m-2,
44.8 ± 4.2% fat) participated in this study. No baseline
differences were exhibited amongst groups for primary,
secondary and tertiary variables of interest, with the
exception of resting energy expenditure (Table 1). Parti-
cipants were not allowed to participate in this study if
they reported at baseline any of the following situations:
1.) presence or diagnosis of any metabolic or cardiovas-
cular disorder including known electrolyte abnormal-
ities; heart disease, arrhythmias, diabetes, thyroid
disease, or hypogonadism; a history of hypertension,
hepatorenal, musculoskeletal, autoimmune, or neurolo-
gic disease; 2.) currently taking or prescribed medica-
tions for hyperlipidemia, hypoglycemia, hypertension, or
androgenic medications; 3.) if they have taken ergogenic
levels of nutritional supplements that may affect muscle
mass (e.g., creatine, HMB), anabolic/catabolic hormone
levels (androstenedione, DHEA, etc.), or weight loss
(e.g., ephedra, thermogenics, etc.) within six months
prior to the start of the study; 4.) were classified as high
risk for cardiovascular disease according to American
College of Sports Medicine criteria; 5) they agreed to
not participate in any other form of a diet or exercise
program during their participation in the study. All eli-
gible participants signed informed consent statements
approved by the institutional review board (IRB) for the
protection of human subjects at Baylor University and
were in compliance with the Declaration of Helsinki.
Testing Sessions
Participants were recruited throughout the community
through advertisements in local newspapers, campus
mailings and television announcements. Those partici-
pants interested in participating first contacted the
laboratory where they underwent a preliminary screen-
ing for the pre-established exclusionary criteria. Eligible
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participants then completed a familiarization which pro-
vided additional education and screening about all
aspects of the study protocol. It was during this time
that contact information, medical history and informed
consent documents were completed. Prior to baseline
testing and all other testing sessions, participants were
instructed to complete a 4 day food record, observe a 10
h fast and refrain from any vigorous activity for at least
24 h prior to testing. In a standardized fashion to con-
trol for natural variations in blood and energy expendi-
ture measures, all reasonable attempts were made to
schedule follow-up assessments at a similar time as
baseline testing. Baseline testing sessions were identical
to the testing sessions after 10 and 14 weeks and con-
sisted of blood collection, anthropometric, resting
energy expenditure, aerobic and anaerobic fitness assess-
ments and body composition analysis using DXA. An
additional testing session occurred after 1 week of diet-
ing and consisted of all measures at baseline with the
exception of aerobic and anaerobic fitness assessments.
After baseline testing, participants in all diet and
exercise groups, with the exception of the CON group,
began weekly 30 min circuit-style resistance training
and callisthenic exercise program, which consisted of
eight bi-directional exercises, interspersed with callisthe-
nic activities. Under the supervision of fitness instruc-
tors, heart rate was monitored during each workout via
palpation of the carotid or radial artery in an effort to
maintain appropriate exercise intensity.
Diet Assignments
Phase I of dieting lasted for one week. During this time,
participants were assigned to follow the prescribed exer-
cise program and follow one of four diet + exercise
combinations (presented as kcals; % carbohydrate: pro-
tein: fat): 1) a high energy, high carbohydrate, low pro-
tein diet (HED) [2,600; 55:15:30%], 2) a very low
carbohydrate, high protein diet (VLCHP) [1,200;
7:63:30%], 3) a low carbohydrate, moderate protein diet
(LCMP) [1,200; 20:50:30%], or 4) a high carbohydrate,
low protein diet (HCLP) [1,200; 55:15:30%]. Phase II
lasted for last for nine weeks, increased caloric intake in
Figure 1 Standard consort diagram. Highlighted divisions include those people who responded to announcement, those who were screened,
group assignments, those who completed program and reasons for termination.
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all restricted groups to 1,600 calories per day and chan-
ged the macronutrient ratios of VLCHP and HCLP to
1,600; 15:55:30%. Further, the HED group altered their
macronutrient ratio 2,600; 40:30:30%. Phase III was a
four week period which had all participants follow the
same diet (2,600; 55:15:30%) and participants were
instructed to weigh themselves each day. Upon gaining
3 pounds, participants were told to follow their phase I
diet until the additional weight was lost. All subjects
were tested over the course of a 14 week period at 0, 1,
10, and 14 weeks to determine any changes in criterion
variables. After baseline testing, participants were
matched into clusters according to body mass and age
into one of six groups and depending on group assign-
ment transitioned through three phases of dieting. Two
control groups were used, a no exercise and no diet
control group (CON) and an exercise-only control (no
diet) group (ND). Phase I dieting lasted for one week
where individuals in the high energy, high carbohydrate,
low protein diet group (HED) followed a 2,600 kcal•d-1
diet, while those participants following a low-calorie diet
consumed a 1,200 kcals•d-1 to stimulate weight loss in
addition to providing a determination of the acute (one
week) adaptations made relative to energy expenditure
and metabolic hormones. These respective diet groups
included a very low carbohydrate, high protein diet
(VLCHP) [1,200; 7:63:30%], a low carbohydrate, moder-
ate protein diet (LCMP) [1,200; 20:50:30%], and a
high carbohydrate, low protein diet (HCLP) [1,200;
55:15:30%]. Phase II dieting lasted nine weeks and incor-
porated an increase in energy intake to 1,600 kcals•d-1
in those diet groups previously consuming 1,200 kcal•d-
Table 1 Baseline anthropometric, body composition, biochemical parameters and dietary analysis for the high energy,
high carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein
diet + exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30),
high carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30) and no diet + no exercise control (CON)
Demographics Grand Mean
(n = 141)
HED
(n = 9)
ND
(n = 5)
VLCHP
(n = 39)
LCMP
(n = 36)
HCLP
(n = 43)
CON
(n = 9)
P-value
Age (years) 39 ± 8 43 ± 7 42 ± 2 38 ± 8 40 ± 7 38 ± 8 32 ± 10 0.06
Height (cm) 163 ± 7 162 ± 8 165 ± 3 163 ± 8 164 ± 7 164 ± 6 163 ± 6 0.95
Weight (kg) 93 ± 17 88 ± 16 93 ± 28 95 ± 18 95 ± 15 93 ± 15 86 ± 17 0.65
Body mass index (kg•m-2) 35 ± 6 33 ± 6 34 ± 11 36 ± 7 36 ± 6 35 ± 5 33 ± 6 0.70
Waist (cm) 98 ± 13 97 ± 6 86 ± 11 99 ± 15 102 ± 14 98 ± 11 92 ± 13 0.12
DXA fat-free mass (kg) 47 ± 7 46 ± 8 47 ± 11 48 ± 7 47 ± 6 48 ± 6 45 ± 7 0.87
DXA fat mass (kg) 39 ± 10 35 ± 9 41 ± 16 39 ± 10 42 ± 10 39 ± 9 35 ± 9 0.28
REE (kcals•d-1) 1632 ± 277 1297 ± 319 1462 ± 246 1690 ± 283f 1642 ± 249f 1642 ± 247f 1720 ± 265f <0.005
Systolic blood pressure (mm Hg) 123 ± 13 122 ± 13 118 ± 4 125 ± 13 122 ± 14 123 ± 13 121 ± 13 0.89
Diastolic blood pressure (mm Hg) 82 ± 8 82 ± 11 81 ± 8 84 ± 10 82 ± 8 82 ± 7 80 ± 7 0.84
VO2 (ml/kg/min) 22 ± 4 24 ± 3 21 ± 4 22 ± 4 21 ± 5 22 ± 3 24 ± 5 0.51
Biochemical parameters Grand Mean HED ND VLCHP LCMP HCLP CON P-value
Total cholesterol (mmol•L-1) 5.0 ± 0.9 5.2 ± 1.0 5.4 ± 1.0 5.1 ± 0.9 5.0 ± 0.8 4.9 ± 1.0 5.1 ± 1.1 0.78
HDL cholesterol (mmol•L-1) 1.3 ± 0.3 1.4 ± 0.3 1.3 ± 0.2 1.3 ± 0.4 1.4 ± 0.3 1.3 ± 0.3 1.2 ± 0.3 0.31
LDL cholesterol (mmol•L-1) 3.0 ± 0.8 3.2 ± 0.9 3.5 ± 1.1 3.0 ± 0.9 2.9 ± 0.7 3.0 ± 0.8 3.2 ± 0.9 0.47
Triglycerides (mmol•L-1) 1.4 ± 0.6 1.2 ± 0.5 1.4 ± 0.3 1.6 ± 0.7 1.4 ± 0.6 1.4 ± 0.6 1.5 ± 0.7 0.73
Glucose (mmol•L-1) 5.4 ± 0.9 5.5 ± 0.5 5.2 ± 0.5 5.5 ± 1.2 5.4 ± 0.9 5.4 ± 0.6 5.1 ± 0.6 0.83
Insulin (pmol•L-1) 271 ± 331 252 ± 333 60 ± 50 351 ± 377 274 ± 410 227 ± 195 N/A 0.33
HOMA-IR 9.6 ± 11.4 9.5 ± 13.7 2.0 ± 1.6 12.5 ± 13.4 9.3 ± 12.9 8.1 ± 7.4 N/A 0.28
Cortisol (μg•dL-1) 34.9 ± 17.5 38.1 ± 31.8 35.6 ± 20.1 33.4 ± 16.7 34.7 ± 14.7 35.7 ± 16.2 N/A 0.96
Ketones (μM) 0.06 ± 0.04 0.18 ± 0.15 0.09 ± 0.09 0.10 ± 0.13 0.08 ± 0.06 0.08 ± 0.06 N/A 0.29
Leptin (pg•mL-1) 21.2 ± 6.4 20.1 ± 6.8 23.0 ± 7.5 22.8 ± 7.9 22.8 ± 7.9 21.2 ± 7.0 N/A 0.76
Dietary Intake Grand Mean HED ND VLCHP LCMP HCLP CON P-value
Caloric intake (kcal/kg/day) 21.7 ± 6.8 23.6 ± 5.3 22.3 ± 4.4 20.9 ± 6.4 21.1 ± 5.1 22.4 ± 8.5 — 0.87
Carbohydrate (g/kg/day) 2.5 ± 0.9 2.8 ± 0.9 2.4 ± 0.4 2.4 ± 0.9 2.4 ± 0.7 2.6 ± 1.1 — 0.24
Protein (g/kg/day) 0.9 ± 0.3 0.7 ± 0.2 0.8 ± 0.1 0.9 ± 0.3 0.9 ± 0.4 0.9 ± 0.3 — < 0.001
Fat (g/kg/day) 0.9 ± 0.3 1.1 ± 0.2 1.1 ± 0.4 0.9 ± 0.2 0.9 ± 0.3 0.9 ± 0.4 — 0.95
All data is presented as means ± SD at baseline. Significance level was set at 0.05. dDifferent than VLCHP, P < 0.001 - 0.05; f Different than HED, P < 0.010. NOTE:
No other differences at baseline existed (P > 0.05).
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1 (e.g., VLCHP, LCHP and HCLP). This slight change
was made in an attempt to help promote steady weight
loss without stimulating negative perturbations of meta-
bolic factors throughout this nine week phase of dieting.
Additionally, slight changes were made to the macronu-
trient distribution of several diets. The HED group
began following a 2,600; 40:30:30% diet and the VLCHP
and LCMP groups began following the same 1,200;
55:15:30% diets. These slight changes were made to
further explore the impact of varying macronutrient dis-
tributions and were made in accordance with our pre-
viously published work [3]. No changes were made to
the ND, CON and HCLP groups. Over the remaining
four weeks (phase III), participants following the low-
calorie diets were instructed to follow a 2,600; 55:15:30%
diet and record their body mass each day. When partici-
pants self-reported a three pound increase in body mass
they were instructed to follow their phase I diet until
they lost the weight they had gained. Upon losing the
weight, they continued to record their body weight each
day while returning to the 2,600 kcal•d-1 diet and only
began dieting after gaining a total of three pounds. This
pattern was continued for the remaining four weeks
where all baseline testing measures were completed. In
an effort to promote adherence and understanding of all
dietary groups, a team of registered dieticians developed
menu booklets which outlined examples of each phase
of dieting, which included several variations to minimize
boredom as well as incorporated substitutions to allow
for more flexibility and personal tastes. Throughout the
study, familiarization sessions were conducted by the
dieticians in addition to being available by phone and
during all testing sessions.
Procedures
Anthropometrics
At the beginning of every testing session, subjects had
their height and body mass measured according to stan-
dard procedures using a Healthometer (Bridgeview, IL)
self-calibrating digital scale with an accuracy of ±
0.02 kg. Waist and hip circumference was measured
using a Golnick tensiometer using standard ACSM cri-
teria [26]. Resting heart rate was measured via palpation
of the radial artery and resting blood pressure was
determined using a mercury sphygmomanometer
according to previously accepted procedures [26].
Dietary Inventories
Prior to each testing session (weeks 0, 1, 10 and 14),
subjects were instructed to record all food and fluid
intake over a 4 d period, which was reflective of their
normal dietary intake and to include one weekend day
and three week days. Dietary inventories were then
reviewed by a registered dietician and analyzed for aver-
age caloric and macronutrient intake using the ESHA
Food Processor (Version 8.6) Nutritional Analysis soft-
ware (Salem, OR) to assess compliance of dietary
assignments.
Body Composition and Energy Expenditure Assessments
During each testing session, resting energy expenditure
assessments were made using a Parvo Medics TrueMax
2400 Metabolic Measurement System (Sandy, UT). This
test was a non-exertional test performed in a fasted
state and involved the subjects lying supine on an exam
table, and having a light blanket placed over them to
keep warm. A clear, hard plastic hood and soft, clear
plastic drape was then placed over the subjects’ neck
and head in order to determine resting oxygen uptake
and energy expenditure. All participants remained
motionless and were instructed to not fall asleep to pre-
vent additional reduction of metabolic rate, for approxi-
mately 20 minutes. Data was only recorded after the
first ten minutes of testing and throughout a five minute
period of time in which criterion variables (e.g., VO2
L•min-1) changed less than 5% [27]. The reported coeffi-
cient of variation in lean, healthy individuals as reported
from the manufacturer for this device was ± 2%. Addi-
tionally, participants had their bone density and body
composition assessed with a whole-body scan using a
Hologic Discovery W DXA using software version 12.1
(Waltham, MA). Previous studies have indicated DXA
to be an accurate and reliable means to assess changes
in body composition [28]. Prior to testing, all partici-
pants were properly informed of any inherent risks that
could possibly be present from radiation exposure.
Briefly, this test involved having the subject lie down on
their back in a standardized position in a pair of shorts/
t-shirt or a gown. A low dose of radiation was then
used to scan their entire body, taking approximately
seven minutes, for determination of bone, fat and mus-
cle mass.
Blood Collection Procedures
Preceding each testing session, participants were
required to fast for 10 h prior to donating approximately
four teaspoons (20 milliliters) of blood from an antecu-
bital vein using standard phlebotomy procedures. Two
serum separation tubes were immediately centrifuged at
1100 × g for 15 min using a standard bench top centri-
fuge (Cole Palmer, Vernon Hills, IL, Model # 17250-10)
prior to having the serum removed and placed into
separate micro centrifuge tubes and frozen at -20°C for
later analysis of clinical chemistry panels and hormone
concentrations. A single lavender top tube containing
K2 EDTA was used for all whole blood measures. This
tube was immediately refrigerated prior to being ana-
lyzed on the same day (typically after 4 - 6 h) for a com-
plete blood count with platelet differentials using an
Abbott Cell Dyn 3500 (Abbott Laboratories, Abbott
Park, IL) automated hematology analyzer (hemoglobin,
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hematocrit, red blood cell counts, MCV, MCH, MCHC,
RDW, white blood cell counts, neutrophils, lymphocytes,
monocytes, eosinophils, baosphils). All serum samples
were analyzed using a Dade Behring Dimension RXL
(Deerfield, IL) automated clinical chemistry analyzer
that was calibrated and optimized according to manu-
facturer guidelines [29]. After centrifugation, each serum
sample was assayed for a standard complete metabolic
panel (glucose, AST, ALT, GGT, albumin, globulin,
sodium, chloride, calcium, carbon dioxide, total biliru-
bin, alkaline phosphatase), thyroid panel (e.g. T3 (triio-
dothyronine), T4 (thyroxine), thyroxine uptake, free
thyroxine index, and thyroid stimulating hormone), lipid
panel (triglycerides, total cholesterol, HDL, LDL, total
cholesterol:HDL) and clinical markers of protein and
fatty acid metabolism (uric acid, creatinine, BUN, BUN:
creatinine ratio, total protein, CK, ketones [betahydroxy-
butyrate], and LDH). In a follow-up fashion, remaining
serum was then assayed using standard commercially
available (DS Laboratories, Webster, TX) enzyme-linked
immunoabsorbent assays (ELISAs) for leptin (DSL-10-
23100), cortisol (DSL-1-2000) and insulin (DSL-10-
1600). Prior to analysis, serum samples were diluted
3-fold to get leptin values within the recommended
standard curve. Serum concentrations were assessed by
determined using a Wallac-Victor IV (Perkin-Elmer Life
Sciences, Boston, MA) micro plate reader at an optical
density of 450 nm against a known standard curve using
standard ELISA procedures according to manufacturer
guidelines.
Cardiopulmonary Exercise Tests
At baseline and after 10 and 14 weeks of following the
diet and exercise program, participants were required to
complete a volitional maximal cardiopulmonary exercise
test according to the Bruce protocol [30]. Using stan-
dard electrode placement and a Quinton 710 ECG unit
(Bothell, WA), 12-lead electrocardiogram tests were
completed to assess heart function according to pre-
viously established criteria [26]. Resting (supine and
standing) ECG, heart rate and blood pressure assess-
ments were made prior to commencing the exercise
test. After the onset of exercise, ECG, heart rate and
blood pressure assessments were taken at the end of
every three minute stage, the earliest point after voli-
tional fatigue and after three minutes of active and three
minutes of passive recovery. Participants were instructed
to perform each test for as long as possible to ensure a
true maximal attempt. Standard ACSM test termination
criteria were monitored and followed throughout each
test [26]. Expired gases (resting and exercise) were col-
lected using a Parvo Medics TrueMax 2400 Metabolic
Measurement System (Sandy, UT) using standard proce-
dures and criteria. Accuracy of the oxygen and carbon
dioxide analyzers for this device was ± 2%.
Maximal Strength and Endurance Assessments
At baseline and after 10 and 14 weeks of following the
diet and exercise program, participants performed one-
repetition maximum (1RM) assessments and then com-
pleted a maximal repetitions to fatigue test using 80% of
their pre-determined 1RM with both the bench press and
leg press. A warm-up of two sets of 10 repetitions at
~50% 1RM was followed by three to five progressive
1RM attempts with two minutes rest in between attempts
using a standard 20 kilogram barbell and a standard
bench found in many fitness facilities (Nebula Fitness,
OH). Once bench press 1RM was determined, subjects
were given five minutes rest and completed a maximal
repetitions to fatigue test with 80% of their pre-deter-
mined 1RM with the bench press to assess upper-body
muscular endurance. Subjects were then given five min-
utes of rest, and had their maximal muscular strength
(1RM) and muscular endurance (80% 1RM repetition to
fatigue) determined using a standard hip sled/leg press
(Nebula Fitness, OH) using similar testing conditions as
the bench press. During all testing sessions, subjects were
equally advised using standardized lifting criteria [31-33]
and encouraged by the testers. Test to test reliability of
performing these strength tests in our lab has yielded low
mean coefficients of variation and high reliability for the
bench press (CV: 1.9%, intra-class r = 0.94) and hip sled/
leg press (CV: 0.7%, intra-class r = 0.91) [34].
Weekly Resistance Training Program
With the exception of the CON group, all participants
were randomized to participate in a supervised exercise
program three days per week each week throughout the
protocol. Each circuit-style workout consisted of eight
bi-directional exercises constructed with pneumatic or
hydraulic resistance that targeted opposing muscle
groups in a concentric-only fashion. Participants were
informed of proper use of all equipment and were
instructed to complete as many repetitions as they could
in a 30 s time period. In an interval fashion, participants
performed floor-based callisthenic exercises for a 30 s
time period after each resistance exercise in an effort to
maintain an exercise heart rate that corresponded to
60% to 80% of their maximum heart rate [26]. All work-
outs were supervised by trained fitness instructors who
assisted with proper exercise technique and maintenance
of an adequate exercise heart rate. Participants were
required to complete three complete circuits, which cor-
responded to exercising for approximately 25 minutes
followed by a standardized whole-body stretching rou-
tine. Attendance was recorded at each workout to moni-
tor compliance to the exercise program.
Statistical Analysis
Data are presented in all tables and throughout the text
as mean ± standard deviation (X SD)± for the HED,
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ND, VLCHP, LCHP, HCLP and CON groups, respec-
tively. Week 14 delta values (week 14 - baseline testing)
were calculated and used for determination of delta
changes across time. Energy expenditure data was first
normalized to body mass in kg before being analyzed
using 6 × 4 (group × test [0, 1, 10 and 14 weeks])
repeated measures ANOVA with Bonferroni corrections
to effectively assess the changes in energy expenditure
after the first phase of dieting, which was the most
hypo-energetic. All remaining data were analyzed using
6 × 3 (group × test [0, 10 and 14 weeks]) repeated mea-
sures ANOVA with Bonferroni corrections. LSD pair-
wise comparisons were used to analyze any significant
group × time interaction effects. When the sphericity
assumption was not met, the conservative Huynh-Feldt
correction was used to determine significance level.
Pearson product correlations were used to determine
any relationship between criterion variables and an
alpha level of 0.05 was adopted throughout to prevent
any Type I statistical errors.
Results
Nutritional Intake and Compliance
All dietary intake was normalized to changes in body
mass and average baseline dietary intake is provided in
table 2. An inadequate number of dietary records were
able to be retrieved from the control (CON) group and
as a result were not analyzed. No significant (p = 0.87)
group × time interaction effect was found for changes in
caloric intake. A main effect for time revealed a signifi-
cant decrease in caloric intake when compared to base-
line after 10 (p < 0.001) and 14 weeks (p < 0.05) of
following the protocol. A significant (p < 0.001) group ×
time interaction effect was revealed for relative protein
intake. As expected, pair wise comparisons revealed that
protein intake significantly (p < 0.05) increased in the
VLCHP and LCMP groups when compared to HCLP.
Relative fat intake exhibited no group × time interaction
effect (p = 0.95), but a significant main effect for time
was yielded (p < 0.05). As expected, reductions in rela-
tive fat intake within all dieting groups led to a signifi-
cant reduction in fat intake after 10 (p < 0.05) and 14
weeks (p < 0.001) of dieting. No significant group ×
time interaction effect (p = 0.24) was found for relative
carbohydrate intake. A significant time effect was found
(p < 0.05) whereby carbohydrate intake was reduced
after 10 weeks (p < 0.05), but returned to baseline levels
after 14 weeks (p = 0.064).
Anthropometric Changes
Anthropometric measurements which included body
mass and waist circumference were recorded after 0, 1,
10 and 14 weeks. Significant main effects for time (p <
0.001) but no significant group × time interaction effect
(p = 0.22) in waist circumference was revealed when all
groups were analyzed together. Restriction of energy
intake while exercising irrespective of macronutrient dis-
tribution (VLCHP, LCMP and HCLP) resulted in a sig-
nificant reduction in waist circumference after 10 weeks
(VLCHP: -4.5 ± 8.2 cm; p < 0.001, LCMP: -5.7 ± 6.6
cm; p < 0.001 and HCLP: -3.4 ± 7.2 cm; p < 0.001) and
continued until 14 weeks (VLCHP: -5.6 ± 9.2 cm; p <
0.001, LCMP: -6.2 ± 7.3 cm; p < 0.001 and HCLP: -4.2
± 6.5 cm; p < 0.001) (Figure 2). No changes (p > 0.05)
were seen at either of these time points for HED, ND
and CON (See table 2). Significant between-group
changes occurred after 14 weeks in VLCHP (-5.6 ± 9.2
cm; p < 0.05) and LCMP (-6.2 ± 7.3 cm; p < 0.05) when
compared to CON (1.6 ± 11.1 cm), but no other groups
(Table 2). When evaluating changes in body mass, a sig-
nificant main effect over time (p < 0.001) in addition to
a significant group × time interaction effect (p < 0.005)
was observed. Changes in body mass also revealed that
those groups which restricted their caloric intake while
exercising, irrespective of macronutrient distribution,
experienced significant reductions in body mass after 1
week (VLCHP: -1.8 ± 1.1 kg; p < 0.001, LCMP: -1.3 ±
1.5 kg; p < 0.001 and HCLP: -1.3 ± 1.0 kg; p < 0.001)
and experienced further reductions from this time point
after 10 weeks of following the program (VLCHP: -4.7 ±
3.2 kg; p < 0.001, LCMP: -3.6 ± 2.9 kg; p < 0.001 and
HCLP: -3.9 ± 4.5 kg; p < 0.001) (Figure 3). Furthermore,
changes in body mass in all restricted energy groups
after 14 weeks were significantly reduced when com-
pared to baseline and week 1, but were not different
than week 10 (Table 2). These changes after 14 weeks
resulted in significantly greater amounts of body mass
loss for all caloric restriction groups (VLCHP: -5.0 ± 4,2
kg; p < 0.001, LCMP: -3.7 ± 3.3 kg; p < 0.01 and HCLP:
-3.6 ± 3.8 kg; p < 0.01) when compared to CON (0.5 ±
± 2.9 kg).
Body Composition
Body composition was assessed using dual-energy x-ray
absorptiometry after 0, 1, 10 and 14 weeks (Table 2). A
significant group × time interaction effect (p < 0.05) for
DXA fat-free mass was reported. Within group changes
over time that all energy restricted group experienced
reductions in DXA fat-free mass, but only those changes
in VLCHP and HCLP were significant. Furthermore,
pair wise comparisons of this effect revealed that signifi-
cant reductions in fat-free mass in VLCHP only
occurred after phase I dieting (-0.8 ± 1.3 kg; p < 0.005)
as DXA fat-free mass values tended to be different after
10 weeks (-0.9 ± 2.1 kg; p = 0.07) and returned to base-
line values after 14 weeks. HCLP changes in DXA fat-
free mass were significant after week 1 (-0.8 ± 1.3 kg; p
< 0.005) and week 10 (-0.7 ± 1.5 kg; p < 0.05) and
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tended to be reduced after 14 weeks (-0.8 ± 1.8 kg; p =
0.051). Interestingly, HED experienced a reduction in
DXA fat-free mass after 14 weeks (-1.5 ± 3.2 kg; p <
0.05) that was significantly different than the changes
seen for CON (0.6 ± 1.5) at this time point. DXA fat
mass experienced a significant main effect over time (p
< 0.001) and a significant group × time interaction effect
(p < 0.05). Significant within group changes were again
seen in all groups that restricted their caloric intake (e.
g., VLCHP, LCMP, HCLP). Significant reductions in fat
mass were seen after 1 week (VLCHP: -0.7 ± 1.0 kg; p <
0.001, LCMP: -0.9 ± 1.2 kg; p < 0.001 and HCLP: -0.6 ±
1.3 kg; p < 0.001) (Figure 4). Even further reductions
were then reported after 10 weeks (VLCHP: -3.6 ± 2.1
Table 2 Anthropometric, body mass, body composition and energy expenditure changes for the high energy, high
carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet
+ exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high
carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30) and control (CON) groups
P-value
Variable Group Week 0 Week 1 Week 10 Week 14 Within Group G × T
Waist (cm) HED 97.0 ± 12.1 93.3 ± 15.3 94.1 ± 11.8 94.4 ± 12.1 0.78 0.22
ND 94.4 ± 22.2 93.7 ± 22.5 91.9 ± 21.3 93.7 ± 25.3 0.83
VLCHP 99.2 ± 15.4 97.7 ± 13.0 94.7 ± 12.7* 93.6 ± 12.5*†a <0.001
LCMP 101.8 ± 13.5 99.4 ± 13.0 96.1 ± 12.2* 95.6 ± 11.6*†a <0.001
HCLP 97.8 ± 11.0 96.1 ± 10.9 94.4 ± 10.8* 93.6 ± 10.4* <0.001
CON 92.3 ± 13.2 91.2 ± 14.2 93.7 ± 14.7 93.8 ± 17.9 0.61
Body Mass (kg) HED 87.5 ± 16.2 86.9 ± 15.2 85.9 ± 13.1 84.0 ± 11.9a 0.26 <0.005
ND 92.6 ± 28.4 92.0 ± 27.7 90.5 ± 27.4 90.1 ± 25.5 0.18
VLCHP 94.5 ± 18.1 92.7 ± 17.8* 89.8 ± 17.6*† 89.5 ± 18.0*†a <0.001
LCMP 95.1 ± 14.9 93.8 ± 14.8* 91.6 ± 14.3*† 91.4 ± 14.1*†a <0.001
HCLP 93.1 ± 15.0 91.8 ± 14.9* 89.2 ± 15.5*† 89.5 ± 14.6*†a <0.001
CON 93.2 ± 16.6 85.8 ± 16.6 87.0 ± 17.4 86.8 ± 18.4 0.42
DXA Fat-Free Mass (kg) HED 46.3 ± 7.9 46.4 ± 7.6 46.6 ± 7.3 44.9 ± 6.3a 0.13 <0.05
ND 47.3 ± 10.8 47.5 ± 10.7 46.7 ± 10.4 47.5 ± 9.2 0.66
VLCHP 48.6 ± 7.8 47.8 ± 7.6* 47.7 ± 7.1 47.8 ± 7.8 <0.05
LCMP 47.0 ± 5.6 46.6 ± 5.5 46.7 ± 5.8 47.0 ± 6.0 0.26
HCLP 47.6 ± 6.0 47.8 ± 5.9* 46.8 ± 5.9 46.8 ± 5.8* <0.05
CON 45.0 ± 7.1 45.1 ± 7.3 45.8 ± 7.3 45.6 ± 8.4 0.18
DXA Fat Mass (kg) HED 35.0 ± 9.0 34.7 ± 8.7 33.4 ± 6.8 33.3 ± 6.7 0.27 <0.05
ND 39.4 ± 16.4 38.8 ± 16.6 37.4 ± 15.0 36.4 ± 14.8 0.08
VLCHP 39.2 ± 10.3 38.5 ± 10.2* 35.7 ± 10.7*† 35.5 ± 10.6*† a <0.001
LCMP 41.8 ± 10.0 40.8 ± 9.9* 38.7 ± 9.5*† 38.3 ± 8.8*† a <0.001
HCLP 39.1 ± 9.4 38.5 ± 9.3* 36.4 ± 9.3*† 36.1 ± 9.2*† a <0.001
CON 34.7 ± 8.9 34.3 ± 8.6 34.7 ± 9.8 34.7 ± 9.7 0.74
DXA % Fat (%) HED 42.7 ± 4.6 42.4 ± 4.8 41.6 ± 3.6 42.4 ± 4.3 0.19 0.09
ND 44.5 ± 4.4 44.0 ± 4.2 43.7 ± 3.5 42.5 ± 4.8 0.22
VLCHP 44.2 ± 4.3 44.1 ± 4.4 42.1 ± 5.0*† 42.0 ± 5.1*†e <0.001
LCMP 46.5 ± 4.6 46.2 ± 4.8 44.9 ± 4.9*† 44.6 ± 4.6*†e <0.001
HCLP 44.6 ± 3.8 44.6 ± 3.9 43.1 ± 4.3*† 43.0 ± 4.4*† <0.001
CON 43.1 ± 2.6 42.8 ± 2.3 42.3 ± 2.6 42.1 ± 2.2 0.08
REE (kcals•d-1) HED 1297 ± 319 1469 ± 260 1391 ± 255 1508 ± 205 0.08 0.08
ND 1462 ± 246 1571 ± 307 1640 ± 269 1585 ± 282 0.19
VLCHP 1690 ± 283 1606 ± 318* 1649 ± 296 1708 ± 298†e <0.01
LCMP 1642 ± 249 1570 ± 222 1616 ± 337 1639 ± 246e 0.18
HCLP 1642 ± 247 1572 ± 266 1648 ± 262† 1659 ± 228†e <0.01
CON 1720 ± 265 1621 ± 281 1708 ± 259 1656 ± 254e 0.62
Dietary intake is presented as calorie intake: % carbohydrate: protein: fat. All data is presented as group means ± standard deviation for week 0, week 1, week 10
and week 14. Individual main effects for time are provided as within-group P-values. Group × time interaction effects are provided as GxT P-values. Between-
group significance indicators represent the delta change from baseline at week 14. Significance level was 0.05. *Different from baseline, P <0.05, †Different than
week 1, P <0.05, aDifferent than CON, P <0.05, eDifferent from HED, P <0.05.
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kg; p < 0.001, LCMP: -3.0 ± 2.6 kg; p < 0.001 and
HCLP: -2.7 ± 2.6 kg; p < 0.001) which were maintained
after 14 weeks (VLCHP: - 3.7 ± 2.9 kg; p < 0.001,
LCMP: -3.5 ± 4.7 kg; p < 0.001 and HCLP: -2.9 ± 2.9
kg; p < 0.001) of following their respective diet and
exercise program (Table 2).
Similarly, DXA % fat values experienced a significant
main effect over time (p < 0.001) while the group ×
time interaction effect approached significance (p =
0.09). Significant within group changes in VLCHP,
LCMP, and HCLP were found after 10 weeks (VLCHP:
-2.1 ± 1.8%; p < 0.001, LCMP: -1.7 ± 2.1%; p < 0.001
and HCLP: -1.5 ± 1.9%; p < 0.001) which were main-
tained after 14 weeks (VLCHP: -2.2 ± 1.8%; p < 0.001,
LCMP: -1.9 ± 2.0%; p < 0.001 and HCLP: -1.6 ± 2.2%;
p < 0.001). Furthermore, these changes resulted in sig-
nificantly greater reductions in DXA % fat in VLCHP
and HCLP groups when compared to the CON group.
Energy Expenditure
Fasting resting energy expenditure measurements (REE)
were obtained at 0, 1, 10 and 14 weeks (Table 2 and Fig-
ure 5). Raw data (kcal•d-1) is provided in table 2 while all
statistical analysis was completed using relative resting
energy expenditure data (kcal•kg•d-1). A significant main
effect for time (p < 0.001) was reported along with a sig-
nificant group × time interaction effect (p < 0.01). After
phase I dieting, non-significant (p > 0.05) reductions
occurred in all energy restricted groups and CON. After
10 and 14 weeks, respectively, all groups (irrespective of
dieting status) reported greater REE values from baseline
with the exception of CON. As expected, the HED group
experienced the greatest increase after 14 weeks in rela-
tive REE (3.3 ± 1.8 (kcal•kg•d-1); a change that was signif-
icantly greater than VLCHP (1.1 ± 2.1 kcal•kg•d-1; p <
0.005), LCMP (0.6 ± 2.0 kcal•kg•d-1; p < 0.001), HCLP
(0.9 ± 2.2 kcal•kg•d-1; p < 0.005) and CON (-0.8 ± 1.8
kcal•kg•d-1; p < 0.001).
Fitness Changes
Maximal cardiopulmonary, muscular strength and mus-
cular endurance assessments were taken after 0, 10 and
14 weeks (Table 3). As expected, all groups that
restricted energy intake and followed the exercise pro-
gram experienced similar significant increases (p < 0.05)
in relative maximal VO2 value (8.8 ± 13.7%), relative
bench press 1RM (16.5 ± 17.8%) and relative leg press
1RM (16.2 ± 16.4%) compared to control group values
Figure 2 Delta change in waist circumference (cm) at 14 weeks. Data are presented as individual changes from baseline. HED = high-
energy, high carbohydrate diet + exercise (n = 9); ND = no diet + exercise (n = 5); VLCHP = very low carbohydrate, high protein diet + exercise
(n = 39); LCMP = Low carbohydrate, moderate protein + exercise (n = 36); HCLP = High carbohydrate, low protein + exercise (n = 43); CON =
no diet + no exercise (n = 9). aDifferent than CON (p < 0.05), bDifferent from ND (p < 0.05).
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of (-0.8 ± 7.4%, 6.5 ± 13.9% and 8.3 ± 17.8%), respec-
tively. Significant main effects for time (p < 0.005) and
group × time interaction effects (p < 0.05) were reported
for maximal aerobic capacity data. Significant increases
in VO2Max were reported after 10 weeks for VLCHP
(2.3 ± 2.7 ml/kg/min; p < 0.001) and HCLP (2.0 ± 2.0
ml/kg/min; p < 0.001); which both remained signifi-
cantly greater (p < 0.005) than baseline after 14 weeks.
Aerobic fitness improved in LCMP, but these changes
were not significant until after 14 weeks (1.5 ± 2.3 ml/
kg/min; p < 0.005). When compared to CON (-0.2 ± 1.9
ml/kg/min), VLCHP (2.0 ± 3.5 ml/kg/min; p < 0.05) and
HCLP (1.8 ± 1.9 ml/kg/min; p < 0.05) groups experi-
enced significantly greater increases in aerobic fitness
after 14 weeks. Interestingly and after 14 weeks of exer-
cise training, the HCLP group (4.1 ± 6.3 kg•kg-1) exhib-
ited significantly greater upper-body strength when
compared to VLCHP (1.9 ± 4.9 kg•kg-1; p < 0.05). Simi-
larly, HCLP lower-body strength changes (15.5 ± 27.6
kg•kg-1) were significantly different than VLCHP (10.1 ±
25.0 kg•kg-1; p < 0.01) and LCMP (12.3 ± 19.2 kg•kg-1;
p < 0.05). While the lifting volume completed for each
group increased as a result of training, none of these
changes were significant.
Lipid Panels
No significant changes in total (p = 0.67), HDL (p = 0.90)
and LDL cholesterol (p = 0.63) as well as serum levels of
triglycerides (p = 0.95) were found for all diet and exer-
cise groups at all time points throughout the investiga-
tion (Table 4). No group × time interaction effects (p >
0.05) were reported. All data can be found in table 4.
Markers of Fuel Utilization and Energy Regulation
The serum samples collected at weeks 0, 10 and 14
weeks were used to assay hormones and selected sub-
strates which were attributed to substrate utilization and
energy regulation. In relation to fuel utilization, serum
levels of glucose, insulin, cortisol and ketones were mea-
sured in addition calculating the homeostatic model
assessment for insulin resistance (HOMA-IR) [35].
Serum levels of the adipokine, leptin, were determined
Figure 3 Delta change in body mass (kg) at 14 weeks. Data are presented as individual changes from baseline. HED = high-energy, high
carbohydrate diet + exercise (n = 9); ND = no diet + exercise (n = 5); VLCHP = very low carbohydrate, high protein diet + exercise (n = 39);
LCMP = Low carbohydrate, moderate protein + exercise (n = 36); HCLP = High carbohydrate, low protein + exercise (n = 43); CON = no diet +
no exercise (n = 9). aDifferent than CON (p < 0.05).
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as an assessment of appetite regulation at 0, 10 and 14
weeks. We were unable to collect an adequate sample
from participants in our control group and as a result
no insulin, HOMA-IR, leptin, ketones and cortisol data
are available for this group (See Table 4). Overall no sig-
nificant group × time interaction effects were seen for
insulin (p = 0.46), glucose (p = 0.85) and HOMA-IR (p
= 0.55). A significant within-group reduction for insulin
did occur in the VLCHP group with the 10 week and 14
week values being significantly reduced from their
respective baseline values. In conjunction, these changes
also led to a significant reduction in HOMA-IR for the
VLCHP group at both the 10 week and 14 week time
points. A significant main effect for time (p < 0.001)
and group × time interaction effect for leptin was
observed (p < 0.05). Significant reductions (from base-
line) after 10 and 14 weeks, respectively occurred in
VLCHP and HCLP while LCMP was significantly
reduced after 14 weeks (table 4). No other significant
(p > 0.05) main effect or group × time interactive effects
were found for all other variables.
Discussion
The purpose of this study was to study how combina-
tions of a regular exercise and diet program can impact
anthropometric and health-related outcomes. Addition-
ally and as we previously attempted [3] we sought to
further examine how replacing dietary carbohydrate
with protein to varying degrees may impact anthropo-
metric and health outcomes in sedentary, obese women
who participated in a regular diet and exercise program.
This study represents the second in a series of studies
our research group has conducted in an attempt to bet-
ter understand how various dietary regimens interact
with an exercise program and what outcomes can be
expected. Currently, the Curves for Women program is
followed at over 10,000 fitness franchises across the
globe with millions of women worldwide following the
program [25]. The study design was based largely upon
our previously published study with slight modification
in phase I dieting, which was decreased to one week in
the present investigation in addition to changes to the
weight maintenance period (Phase III). Similar to our
previous study, this employed study design has certain
strengths such as the overall number of subjects, incor-
poration of adequate control groups, dietary oversight,
and exercise supervision. A potential area of weakness is
the unbalanced distribution of participants across all
groups which took place as part of study design. The
authors acknowledge that increasing (and/or equating)
Figure 4 Delta change in DXA fat mass (kg) at 14 weeks. Data are presented as individual changes from baseline. HED = high-energy, high
carbohydrate diet + exercise (n = 9); ND = no diet + exercise (n = 5); VLCHP = very low carbohydrate, high protein diet + exercise (n = 39);
LCMP = Low carbohydrate, moderate protein + exercise (n = 36); HCLP = High carbohydrate, low protein + exercise (n = 43); CON = no diet +
no exercise (n = 9). aDifferent than CON (p < 0.05).
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sample size in every group would have addressed this
concern and would have been helpful, the primary
objective of our study was to determine the impact of
different macronutrient distributions and how this
alteration impacted the end points measured in the pre-
sent study. In this respect, however, statistical power
analysis of our primary and secondary outcomes
revealed power values that ranged from 0.767 - 0.944
and partial eta squared values which ranged from 0.055
- 0.092; providing evidence of appropriate statistical
power on our primary and secondary outcomes. We
initially hypothesized that following a diet and exercise
program would improve all primary and secondary out-
comes (waist circumferences and other anthropometric
and body composition variables) in comparison to the
control groups (no diet + no exercise [CON] and no
diet + exercise [ND]). We also hypothesized that those
groups ingesting a higher proportion of dietary protein
(VLCHP and LCMP) would experience improved
responses in our primary and secondary outcomes. The
primary findings from this study confirmed our initial
hypothesis that following any form of caloric restriction
along with the exercise program led to greater
improvements in waist circumference (primary) and
other secondary outcomes (body mass, DXA fat mass,
DXA % fat, resting energy expenditure) in addition to
improvements in fitness parameters. This finding also
provides continued support that exercise participation
alone cannot adequately promote improvements in
these end points, a conclusion we [3] and others have
previously made [36].
A critical component to our study design and investi-
gated questions was the compliance to the recom-
mended dietary regimens prescribed to all groups. As
expected, significant changes did occur for energy, car-
bohydrate and protein intake between diet phases (e.g.,
Phase I, Phase II, etc.) and dietary groups (e.g., VLCHP
and LCMP vs. HCLP). From an overall standpoint, com-
pliance to the dietary regimens was somewhat success-
ful, but some deviations did result in an inability to
make all a priori comparison. In this respect, the HED
group was unable to achieve the prescribed energy
intake of 2,600 kcals•-1; a response which we reported
in our initial investigation [3]. Their mean intake of
1,800 kcals•d-1 was approximately 800 kcals•d-1 lower
than prescribed, but was still 320 kcals•d-1 greater than
Figure 5 Delta change in absolute resting energy expenditure (kcals•d-1) at 0, 10 and 14 weeks HED = high-energy, high
carbohydrate diet + exercise (n = 9); ND = no diet + exercise (n = 5); VLCHP = very low carbohydrate, high protein diet + exercise
(n = 39); LCMP = Low carbohydrate, moderate protein + exercise (n = 36); HCLP = High carbohydrate, low protein + exercise (n = 43);
CON = no diet + no exercise (n = 9). ‡Different from all groups except ND (p < 0.05), †Different from all three diet groups (e.g., VLCHP, LCMP,
HCLP) (p < 0.05).
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the average intake of the other restricted diet groups
(e.g., VLCHP, LCMP, HCLP). The higher value still
allowed for comparisons between caloric intakes while
exercising, which was the main reason for this dietary
prescription, even though the associated adaptations we
hoped to compare likely did not occur to the extent we
planned. The 30% error rate commonly associated with
dietary reporting may have contributed to this, and in
addition previous reports have suggested that greater
errors occur when higher caloric intakes are prescribed.
It is also likely that the relatively low fat intake at such
a high caloric intake resulted in an overall higher
volume of food that was prohibitive versus ingesting a
lower volume of higher energy density foods common
in the North American diet. Caloric intake, however,
was reduced overall by an average of 504 kcals•d-1 in
the diet groups (e.g., VLCHP, LCMP, HCLP) from their
baseline intakes, which was deemed as a positive
response to the prescribed dietary regimens. Lastly and
an important point we reported before relates to the
relative daily intake of protein for the VLCHP and
LCMP groups and inherent safety or risks of this regi-
men. While both groups ingested a much greater pro-
portion of calories as protein (~50 - 60% daily energy
from protein), their relative daily intake of protein (~1.1
gram protein•kg•d-1) was not much greater than RDA
Table 3 Cardio respiratory and muscular fitness changes for the high energy, high carbohydrate diet + exercise (HED;
2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exercise (VLCHP: 1,200; 63:7:30),
low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high carbohydrate, low protein diet +
exercise (HCLP: 1,200; 55:15:30)
P-value
Variable Group Week 0 Week 10 Week 14 Within Group G × T
Max VO2 (mL•kg•min
-1) HED 23.5 ± 3.2 22.9 ± 4.6 24.6 ± 3.9 0.22 <0.05
ND 21.4 ± 4.1 22.2 ± 4.0 21.9 ± 3.5 0.45
VLCHP 21.6 ± 4.0 23.9 ± 4.3* 23.5 ± 4.4* a <0.001
LCMP 21.3 ± 4.6 22.0 ± 5.2 22.8 ± 4.7* <0.05
HCLP 21.7 ± 3.4 23.8 ± 4.4* 23.5 ± 3.9*a <0.001
CON 23.7 ± 4.9 24.0 ± 5.6 23.5 ± 4.9 0.80
BP 1RM (kg•kg-1) HED 0.41 ± 0.09 0.46 ± 0.08 0.49 ± 0.08* <0.001 0.39
ND 0.36 ± 0.07 0.39 ± 0.05 0.42 ± 0.09* 0.053
VLCHP 0.39 ± 0.13 0.43 ± 0.12* 0.43 ± 0.12*f <0.001
LCMP 0.36 ± 0.09 0.40 ± 0.09* 0.41 ± 0.09* <0.001
HCLP 0.36 ± 0.08 0.41 ± 0.09* 0.42 ± 0.09* <0.001
CON 0.35 ± 0.09 0.37 ± 0.10 0.37 ± 0.09 0.36
BP Lifting Volume (kg•kg-1) HED 5.1 ± 1.8 5.1 ± 3.7 5.2 ± 4.5 0.98 0.91
ND 5.5 ± 2.7 5.3 ± 1.9 4.5 ± 1.7 0.64
VLCHP 4.2 ± 2.0 4.8 ± 3.1 4.5 ± 2.7 0.30
LCMP 4.6 ± 2.3 4.9 ± 1.9 4.7 ± 2.0 0.75
HCLP 5.2 ± 2.5 5.2 ± 2.3 5.1 ± 2.2 0.87
CON 4.1 ± 2.4 5.2 ± 2.0 5.2 ± 1.4 0.33
LP 1RM (kg•kg-1) HED 2.1 ± 0.5 2.3 ± 0.6 2.3 ± 0.6 0.10 0.24
ND 1.6 ± 0.3 1.7 ± 0.2 1.8 ± 0.3 0.08
VLCHP 1.9 ± 0.4 2.0 ± 0.5* 2.1 ± 0.5*f <0.001
LCMP 1.8 ± 0.5 1.9 ± 0.5* 2.0 ± 0.5*f <0.001
HCLP 1.7 ± 0.5 2.0 ± 0.5* 2.1 ± 0.5* <0.001
CON 1.9 ± 0.5 1.9 ± 0.3 2.0 ± 0.4 0.63
LP Lifting Volume (kg•kg-1) HED 49 ± 30 59 ± 42 56 ± 60 0.61 0.53
ND 45 ± 19 56 ± 32 38 ± 20 0.48
VLCHP 47 ± 26 42 ± 21 47 ± 19 0.29
LCMP 42 ± 17 48 ± 24 47 ± 24 0.25
HCLP 45 ± 21 48 ± 34 46 ± 25 0.64
CON 41 ± 12 43 ± 19 46 ± 21 0.47
Dietary intake is presented as calorie intake: % carbohydrate: protein: fat. All data is presented as group means ± standard deviation for week 0, week 10 and
week 14. Individual main effects for time are provided as within-group P-values. Group × time interaction effects are provided as GxT P -values. Between-group
significance indicators represent the delta change from baseline at week 14. Significance level was 0.05. *Different from baseline, P <0.05, aDifferent than CON,
P <0.05, fDifferent than HCLP, P <0.05.
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Table 4 Lipid panel, glucose and selected markers of fuel status and utilization for the high energy, high
carbohydrate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet
+ exercise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high
carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30)
P-value
Variable Group Week 0 Week 10 Week 14 Within Group G × T
Total Cholesterol (mmol•L-1) HED 5.2 ± 1.0 4.8 ± 0.9* 5.1 ± 1.3 0.12 0.67
ND 5.4 ± 1.0 5.1 ± 1.5 5.0 ± 1.0 0.33
VLCHP 5.2 ± 1.0 5.2 ± 1.1 5.1 ± 1.2 0.84
LCMP 4.9 ± 1.0 4.7 ± 0.9 5.0 ± 0.7 0.11
HCLP 4.9 ± 0.9 4.6 ± 0.9 4.7 ± 0.8 0.11
CON 5.1 ± 1.1 4.6 ± 1.1 4.9 ± 1.1 <0.01
HDL Cholesterol (mmol•L-1) HED 1.4 ± 0.3 1.3 ± 0.2 1.4 ± 0.2 0.16 0.90
ND 1.3 ± 0.2 1.3 ± 0.2 1.3 ± 0.2 0.55
VLCHP 1.3 ± 0.4 1.3 ± 0.3 1.3 ± 0.4 0.94
LCMP 1.4 ± 0.4 1.3 ± 0.3 1.4 ± 0.3 0.18
HCLP 1.3 ± 0.2 1.3 ± 0.3 1.3 ± 0.3 0.86
CON 1.2 ± 0.3 1.2 ± 0.2 1.2 ± 0.3 0.81
LDL Cholesterol (mmol•L-1) HED 3.2 ± 0.9 2.9 ± 0.7 3.2 ± 1.1 0.10 0.63
ND 3.5 ± 1.1 3.3 ± 1.6 3.3 ± 1.2 0.55
VLCHP 3.1 ± 0.8 3.2 ± 0.9 3.1 ± 1.0 0.97
LCMP 2.8 ± 0.7 2.7 ± 0.7 2.9 ± 0.6 0.16
HCLP 3.0 ± 0.7 2.8 ± 0.8 2.9 ± 0.7 0.28
CON 3.2 ± 0.9 2.8 ± 1.0 3.0 ± 0.8 0.07
Triglycerides (mmol•L-1) HED 1.2 ± 0.5 1.2 ± 0.4 1.2 ± 0.6 0.89 0.95
ND 1.4 ± 0.3 1.0 ± 0.3* 1.0 ± 0.2 0.07
VLCHP 1.6 ± 0.7 1.4 ± 0.9 1.5 ± 0.9 0.09
LCMP 1.4 ± 0.7 1.3 ± 0.6 1.3 ± 0.5 0.10
HCLP 1.3 ± 0.6 1.2 ± 0.5* 1.2 ± 0.5 <0.05
CON 1.5 ± 0.7 1.3 ± 0.8 1.5 ± 0.9 0.80
Insulin (pmol•L-1) HED 252 ± 333 211 ± 312 206 ± 313 0.08 0.46
ND 60 ± 50 53 ± 46 154 ± 226 0.43
VLCHP 351 ± 377 292 ± 341* 294 ± 325*b <0.005
LCMP 274 ± 410 233 ± 392 245 ± 398 0.23
HCLP 227 ± 19 187 ± 200 200 ± 218 0.13
CON
Glucose (mmol•L-1) HED 5.5 ± 0.5 5.8 ± 0.5 5.6 ± 0.5 0.20 0.85
ND 5.2 ± 0.5 5.3 ± 1.3 5.1 ± 0.5 0.86
VLCHP 5.5 ± 1.3 5.7 ± 1.9 5.6 ± 1.9 0.33
LCMP 5.4 ± 1.0 5.4 ± 0.6 5.3 ± 0.6 0.39
HCLP 5.4 ± 0.8 5.4 ± 0.6 5.2 ± 0.6 <0.05
CON 5.1 ± 0.6 5.0 ± 0.6 4.9 ± 0.9 0.75
HOMA-IR HED 9.5 ± 13.7 8.1 ± 11.9 7.3 ± 10.6 0.11 0.55
ND 2.0 ± 1.6 1.7 ± 1.3 5.3 ± 7.8 0.42
VLCHP 12.5 ± 13.4 10.9 ± 12.5 10.5 ± 11.6* b <0.05
LCMP 9.3 ± 12.9 8.0 ± 12.6 7.8 ± 10.9 0.21
HCLP 8.1 ± 7.4 6.6 ± 7.4 6.8 ± 7.6 0.11
CON
Leptin (pg•mL-1) HED 21.2 ± 6.4 19.4 ± 4.0 18.6 ± 5.9 0.33 <0.05
ND 20.1 ± 6.8 15.4 ± 8.8 19.1 ± 7.9 0.18
VLCHP 23.0 ± 7.5 17.1 ± 7.4* 18.0 ± 7.2* <0.001
LCMP 22.8 ± 7.9 21.8 ± 8.3 20.1 ± 7.8* <0.05
HCLP 21.2 ± 7.0 17.8 ± 7.0* 17.8 ± 7.7* <0.001
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guidelines. This result is consistent with our previous
work [3], but is a lower overall protein intake than what
other investigators have employed in similar study
designs [6].
Waist circumference was chosen as a primary out-
come due to its ability to serve as a predictor of dia-
betes, cardiovascular disease and other comorbidities
[37]. As previously reported, results from this study
reveal that regular participation in a resistance-based
exercise program, when combined with energy restric-
tion, significantly reduces waist circumference [3]. Inde-
pendent of macronutrient distribution, reductions in
waist circumference were significant over time and
greater than CON (Figure 2). Similarly, body mass was
also found to significantly decrease in those groups that
followed the exercise program and restricted energy
intake (Figure 3). No between-group differences were
found for those groups that replaced more carbohydrate
with protein (VLCHP and LCMP vs. HCLP), although
slightly greater decreases in waist circumference and
body mass did occur (Table 2); an outcome identical to
our previous report [3]. Overall these findings provide
support for previous studies in diabetic and non-diabetic
populations which also investigated the impact of
macronutrient content on changes in weight loss
[9,38,39]. While none of the studies incorporated an
exercise program, our findings refute conclusions made
by Layman et al. who suggested that greater total weight
loss occurs, independent of exercise participation when
increased dietary protein intake occurs [22]. While
greater changes did occur in those groups that ingested
more protein in the present, the changes were not sta-
tistically significant and thus can’t be considered real
effects. Furthermore, those participants who restricted
energy intake and exercise all lost significant amounts of
fat mass (Figure 4) and percent fat (Table 2), but again
no between-group differences were evident. It is particu-
lar interesting to note that only the HCLP group experi-
enced a significant reduction in DXA fat-free mass after
completion of the 14-week program. This decrease
resulted in a change in DXA fat-free mass that was sig-
nificantly different than changes in CON after 14 weeks,
but the changes were not different than any other
groups in the study. At some level, this finding supports
our second hypothesis that a greater intake of dietary
protein would spare losses of fat-free mass while
restricting energy intake. It has been reported that
higher intakes of dietary protein during dieting can pre-
vent losses of lean mass, however, these findings are
somewhat mixed [9,22]. Careful interpretation of these
data is encouraged as the discussed changes are only
within the HCLP and are not a between-group finding.
Nonetheless, these findings do suggest that significant
amounts of fat can be lost in comparison to changes in
fat-free mass while dieting and exercising [5,21], and to
a greater extent than control conditions.
An untoward metabolic response to energy restriction
is a decrease in energy expenditure [3,38,40]. Our first
investigation had participants restrict energy intake to
1,200 kcals•d-1 for two weeks, which resulted in a signif-
icant reduction in energy expenditure [3]. To minimize
this counteractive response, dieters in the present study
Table 4 Lipid panel, glucose and selected markers of fuel status and utilization for the high energy, high carbohy-
drate diet + exercise (HED; 2,600: 55:15:30), no diet + exercise (ND), very low carbohydrate, high protein diet + exer-
cise (VLCHP: 1,200; 63:7:30), low carbohydrate, moderate protein diet + exercise (LCMP: 1,200; 50:20:30), high
carbohydrate, low protein diet + exercise (HCLP: 1,200; 55:15:30) (Continued)
CON
Ketones (uM) HED 0.06 ± 0.04 0.06 ± 0.04 0.16 ± 0.25 0.23 <0.05
ND 0.18 ± 0.15 0.21 ± 0.15 0.37 ± 0.64 0.50
VLCHP 0.09 ± 0.09 0.14 ± 0.19 0.08 ± 0.06 0.13
LCMP 0.10 ± 0.13 0.10 ± 0.11 0.07 ± 0.05 0.34
HCLP 0.08 ± 0.06 0.10 ± 0.07 0.07 ± 0.05 0.06
CON
Cortisol (nmol•L-1) HED 1051 ± 878 1049 ± 692 833 ± 353 0.48 0.75
ND 982 ± 556 1039 ± 485 855 ± 366 0.53
VLCHP 921 ± 462 1011 ± 557 954 ± 439b, e 0.37
LCMP 957 ± 405 939 ± 370 914 ± 413b, e 0.79
HCLP 986 ± 447 949 ± 446 945 ± 487b 0.82
CON
Dietary intake is presented as calorie intake: % carbohydrate: protein: fat. All data is presented as group means ± standard deviation for week 0, week 10 and
week 14. Individual main effects for time are provided as within-group P-values. Group × time interaction effects are provided as G × T P-values. Between-group
significance indicators represent the delta change from baseline at week 14. Significance level was 0.05. NOTE: Insulin, HOMA-IR, leptin, ketones and cortisol were
not run on the CON group due to an inability to collect an appropriate numbers of samples. *Different from baseline, P <0.05, bDifferent from ND, P <0.05,
eDifferent from HED, P <0.05.
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restricted calories to 1,200 kcals•d-1 for only week in the
present study. While all groups who followed a diet
reported a reduction in energy expenditure, only the
changes in VLCHP were significant after one week (~84
kcals•d-1). Regular participation in the exercise program
for 9 weeks returned these values to baseline and in two
groups (VLCHP and HCLP) a significant increase
occurred in comparison to week one values (Figure 5).
Mixed outcomes have been reported for the influence of
an exercise program to stimulate energy expenditure
values [22,41]. Irrespective of these differences, findings
from this and our previous investigation demonstrate its
successful ability to sustain energy expenditure levels
near basal rates, independent of what diet program was
being followed (Figure 5).
As we reported previously and as expected, within-
group improvements in relative aerobic capacity and
relative maximal strength occurred in those groups who
followed a diet and exercised [3,21]. While absolute
aerobic capacity (L/min) and strength (1RM) did
increase (data not shown) in the no diet + exercise and
HED groups, the lack of body mass change precluded
statistical significance when represented relative to the
body mass changes that occurred (or didn’t occur) in
these groups. In addition to the changes in fitness sta-
tus, serum values for total cholesterol, LDL cholesterol
and triglycerides decreased non-significantly from the
beginning to the end of the protocol (Table 4). Overall
the magnitude of changes are less than what has been
previously reported [5,6], but inherent differences in the
study designs (presence of exercise program, length of
study, protein type and quality, dietary compliance, etc.)
in the investigative approaches may explain some of
these differences. Overall it remains that regular partici-
pation in a diet and exercise and program can help
maintain serum and/or promote improvements in
serum based measures of cholesterol metabolism and
cardiovascular health.
Great interest has developed into understanding the
impact of leptin regulation in conjunction with weight
loss, energy expenditure and insulin sensitivity
[17,42,43]. It has been well documented that circulating
leptin decreases in response to a decreases in energy
availability [42], however, the influence of exercise and
alterations in the macronutrient ratio is still under-
researched. As expected, circulating leptin in the pre-
sent study decreased in all groups who restricted caloric
intake, but no differences relative to macronutrient ratio
were determined. Volek et al. [17] reported significant
decreases in leptin after an 8-week weight loss program;
a finding similar to other studies [3] and the present
study. Using a combined diet and exercise approach,
Sartorio et al. [42] reported acute, significant reduction
in leptin which closely mimicked body mass changes;
again a finding supported by the present study and our
previous reports [3]. Briefly, previous studies have sug-
gested that diets which contain a higher proportion of
dietary protein may promote homeostasis of glucose
and insulin [7]. In support of these findings, fasting
insulin levels in the VLCHP group were the only group
to experience significant reductions from baseline
(Table 4) after following their prescribed diet and exer-
cise program after 14 weeks. This response also led to a
subsequent significant decrease in HOMA-IR, a homeo-
static model of insulin resistance. No significant changes
in serum levels of ketones and cortisol were found
(Table 4).
The overall safety of higher protein diets has been
questioned in the literature. Findings from the current
study support findings from our previous investigation
using a similar investigative approach that no significant
changes occurred in any diet or exercise groups for var-
ious markers of kidney and liver function as well as var-
ious markers of protein breakdown, which provide
additional support for higher protein diets in conjunc-
tion with a regular exercise program (data not shown).
Nonetheless, it remains that this study and multiple pre-
viously published investigations provide evidence that a
higher relative protein intake do not invoke negative
alterations in any of these serum variables in sedentary,
obese, but otherwise healthy populations [1,17,39,44].
Conclusions
The dietary approaches and exercise program employed
through this investigation successfully stimulated signifi-
cant decreases in waist circumference, body mass, and
fat mass, which resulted in an overall improvement in
body composition. While other dieting programs have
resulted in a decrease in overall energy expenditure in
response to acute reductions in energy intake (1,200
kcals•d-1), results of the present study indicate that
while resting energy expenditure decreased following the
first week of dieting, the exercise and dietary approach
employed was effective in allowing resting energy expen-
diture to return toward baseline during the subsequent
nine weeks of dieting and during the maintenance
phase. Serum levels of cholesterol non-significantly
improved while fasting insulin values were significantly
improved in those individuals who replaced dietary car-
bohydrate with dietary protein to the greater extent
(VLCHP) and serum leptin levels were significantly
improved in all groups that restricted energy intake and
followed the exercise program. As a result, when seden-
tary, obese women followed a restricted energy intake
diet, independent of macronutrient distribution, along
with a weekly exercise program over a period of 14
weeks, significant reductions in waist circumference,
body mass, and improvements in body composition
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resulted along with general improvements in fitness sta-
tus and serum markers of energy regulation without
negative changes in various markers of clinical safety.
While findings from the present study and others help
to elucidate the changes seen in healthy but obese
women, minimal data exists for pre-diabetic and type 2
diabetic populations. In this regard, future studies
should consider investigating varying combinations of
diets which restrict energy intake and varying propor-
tions of the macronutrients along with a regular exercise
program over the course of several months to determine
the efficacy of these interventions in metabolically chal-
lenged and other clinically significant populations.
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